The situation
A brand team sits with a near-final visual aid, days before it goes for internal review. Every page carries the company name into thousands of doctor calls, where a medical representative has two to three minutes to present data credibly and land a clear message.
The team knows the material is close. What it cannot easily see, on its own pages, is whether every claim, every visual, and every line of messaging would hold up to an experienced reviewer reading it cold.
The real question for a brand team is whether it can stand behind every page with confidence before the material goes forward. In a survey of 100 clinicians at a teaching hospital in Pune, brochures were rated the most useful form of drug promotional literature, ahead of interactions with medical representatives. In the same survey, 69% felt that the claims in promotional literature are balanced but supported by poor evidence, and 95% said they spend time researching a drug after seeing its promotional literature (Sharma et al., 2021). The doctors in this survey valued the page, and they checked it. The quality of the page shapes the quality of the conversation it supports.
The pilot
The team chose five pages and ran them through Collateral Advisor, a structured five-dimension review of every page: medical accuracy, regulatory compliance, visual design, messaging clarity, and content structure. Nothing changed in the team’s own process. The review sat alongside it as a structured second eye, before the material went forward.
Two moments from that pilot show what a structured second eye adds.
It clarified an open question on the messaging
On one page, a finding on the messaging clarified something the team had been unsure about, and the team chose to act on it. The value was a sharper way to see a page the team already knew well.
It matched their experts’ judgement
On another page, the review arrived at the same change the team’s own medical reviewers would later recommend. An independent read reaching the same judgement as the team’s experts is what lets a team stand behind a page with more confidence.
Neither moment was a verdict. The product does not approve a page or reject it. It offers an experienced reviewer’s structured perception, and the decision stays with the team. What the team gained across both pages was the same thing: more confidence that what it was sending forward could stand up to scrutiny.
We piloted five pages. On one, we directly followed a suggestion that clarified something our team had been unsure about. On another, the portal had also flagged the same change our medical team recommended.Marketing Manager, one of India’s largest pharmaceutical companies
Curious what it would flag on your pages?
Use old or sample collateral. No card needed. Two free assessments.
From pilot to wider use
The pilot did not stay a one-time test. Within about a month the team subscribed, following an endorsement from the business unit head to the team, with access extending to each division.
When visual-aid preparation for the next cycle began, nine members of the team brought their in-progress pages to the review. In under three weeks they ran more than forty assessments. Two things had changed since the pilot.
The unit of review grew
The pilot looked at single pages. In the next cycle, four team members put complete multi-page collaterals through the review, the longest running to twenty-five pages.
The team went past the report
Every one of the nine opened the designer review, the step where findings can be carried forward as change instructions for the designer. Which findings to carry forward stays the brand manager’s call. The review makes the change easier to brief precisely.
A team brings its real, in-progress pages to a review only when it trusts what the review gives back.
The takeaway
On one page the review gave the team a sharper way to see its own work. On another it arrived at the same judgement as the team’s medical experts, which let the team stand behind the page with more confidence. When the next cycle came, the team returned with more people and with whole collaterals. Collateral Advisor is an assistant, never an authority. It offers an experienced reviewer’s structured perception, and the final decision stays with the team and its internal medical and regulatory reviewers. What it leaves behind is a brand team that can send its work forward more defensibly.
See what an experienced eye would find
Run your own collateral through the same five-dimension review, before it goes for internal review.
Use old or sample collateral. No card needed. Two free assessments.
Reference: Sharma S, Akhoon N, Moe HW, Nair DR, Shashidhar V. A study of perceptions and exposure of drug promotional literature among clinicians in a teaching hospital. Perspect Clin Res 2021;12:140-5. DOI 10.4103/picr.PICR_36_19. A single-centre questionnaire survey of 100 clinicians.
The customer is kept anonymous at their preference. The quoted feedback is reproduced as it was given. Any usage detail reflects this customer’s own activity on Collateral Advisor. MarketingSense Collateral Advisor provides advisory review ahead of a company’s own internal review. Results are advisory only, and are not legal, regulatory, or medical advice. Always verify findings with your medical and regulatory team.